Neuronetics (STIM) Gross Profit (2017 - 2026)

Neuronetics (STIM) has 10 years of Gross Profit data on file, last reported at $16.2 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 2.64% year-over-year to $16.2 million in Q1 2026; TTM through Mar 2026 was $72.7 million, a 28.01% increase from a year earlier, with the FY2025 full-year figure at $72.3 million, up 33.51% from the prior year.
• Gross Profit for Q1 2026 stood at $16.2 million, down from $21.7 million in the prior quarter.
• Over the last five years, Gross Profit for STIM reached as high as $21.7 million in Q4 2025 and fell as low as $10.7 million in Q1 2022.
• Historically, Gross Profit has averaged $14.4 million across 5 years, with a median of $13.8 million in 2022.
• Across the five-year window, Gross Profit fell 9.0% in 2023 and soared 45.81% in 2025, its largest moves.
• Year by year, Gross Profit stood at $13.8 million in 2022, then climbed by 14.22% to $15.8 million in 2023, then decreased by 5.57% to $14.9 million in 2024, then surged by 45.73% to $21.7 million in 2025, then decreased by 25.57% to $16.2 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $16.2 million in Q1 2026, $21.7 million in Q4 2025, and $17.1 million in Q3 2025.